Universal Health Services, Inc. $UHS Stock Holdings Lessened by Amundi

Key Points

• Amundi has reduced its stake in Universal Health Services, Inc. by 25.4% during the first quarter, now holding 0.41% of the company valued at approximately $50.67 million.
• Multiple analysts have adjusted their price targets for Universal Health Services, with estimates ranging from $185.00 to $227.00, signaling mixed sentiments about the stock's future performance.
• The company recently announced a quarterly dividend of $0.20, with a dividend yield of 0.4%, set to be paid on September 16th.

Amundi trimmed its position in Universal Health Services, Inc. (NYSE:UHS - Free Report) by 25.4% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 268,480 shares of the health services provider's stock after selling 91,590 shares during the period. Amundi owned about 0.41% of Universal Health Services worth $50,670,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Stifel Financial Corp increased its stake in shares of Universal Health Services by 21.9% during the 4th quarter. Stifel Financial Corp now owns 4,880 shares of the health services provider's stock valued at $876,000 after acquiring an additional 878 shares during the last quarter. Ameriprise Financial Inc. grew its holdings in Universal Health Services by 82.8% in the fourth quarter. Ameriprise Financial Inc. now owns 94,275 shares of the health services provider's stock valued at $16,916,000 after purchasing an additional 42,714 shares during the period. BOKF NA acquired a new position in Universal Health Services during the fourth quarter worth approximately $539,000. Cetera Investment Advisers increased its position in Universal Health Services by 30.6% during the fourth quarter. Cetera Investment Advisers now owns 12,858 shares of the health services provider's stock worth $2,307,000 after purchasing an additional 3,011 shares during the last quarter. Finally, Crestline Management LP purchased a new position in Universal Health Services during the fourth quarter worth approximately $253,000. 86.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on UHS shares. Royal Bank Of Canada upped their price target on Universal Health Services from $201.00 to $206.00 and gave the stock a "sector perform" rating in a research note on Tuesday, August 19th. JPMorgan Chase & Co. cut their target price on shares of Universal Health Services from $215.00 to $195.00 and set a "neutral" rating on the stock in a research note on Monday, August 4th. Wells Fargo & Company reduced their target price on shares of Universal Health Services from $225.00 to $210.00 and set an "overweight" rating on the stock in a report on Thursday, August 14th. Bank of America lowered Universal Health Services from a "neutral" rating to an "underperform" rating and reduced their price target for the stock from $215.00 to $185.00 in a research report on Wednesday, July 16th. Finally, Barclays increased their price objective on shares of Universal Health Services from $257.00 to $259.00 and gave the company an "overweight" rating in a research report on Wednesday, July 30th. Four equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Universal Health Services has a consensus rating of "Hold" and a consensus price target of $214.77.

Universal Health Services Stock Up 0.4%

Shares of UHS traded up $0.79 during midday trading on Tuesday, hitting $186.55. The company had a trading volume of 461,388 shares, compared to its average volume of 665,957. The stock has a market cap of $11.87 billion, a price-to-earnings ratio of 9.82, a PEG ratio of 0.77 and a beta of 1.28. The company's 50 day moving average price is $176.31 and its 200 day moving average price is $178.51. The company has a quick ratio of 1.19, a current ratio of 1.29 and a debt-to-equity ratio of 0.64. Universal Health Services, Inc. has a 52 week low of $152.33 and a 52 week high of $243.25.

Universal Health Services (NYSE:UHS - Get Free Report) last announced its quarterly earnings data on Monday, July 28th. The health services provider reported $5.35 earnings per share for the quarter, beating the consensus estimate of $4.85 by $0.50. Universal Health Services had a return on equity of 18.25% and a net margin of 7.66%.The firm had revenue of $4.28 billion during the quarter, compared to analyst estimates of $4.24 billion. During the same period in the previous year, the company earned $4.31 earnings per share. Universal Health Services's quarterly revenue was up 9.6% on a year-over-year basis. Universal Health Services has set its FY 2025 guidance at 20.000-21.000 EPS. On average, equities research analysts predict that Universal Health Services, Inc. will post 15.92 EPS for the current year.

Universal Health Services Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 16th. Investors of record on Tuesday, September 2nd will be paid a dividend of $0.20 per share. The ex-dividend date is Tuesday, September 2nd. This represents a $0.80 annualized dividend and a yield of 0.4%. Universal Health Services's dividend payout ratio (DPR) is 4.21%.

Universal Health Services Company Profile

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.